title: Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
authors.affiliation: Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA. m-gheorghiade@northwestern.edu
authors.forename: Mihai
authors.initials: M
authors.lastname: Gheorghiade
authors.forename: Wendy A
authors.initials: WA
authors.lastname: Gattis
authors.forename: Kirkwood F
authors.initials: KF
authors.lastname: Adams
authors.forename: Alan S
authors.initials: AS
authors.lastname: Jaffe
authors.forename: Christopher M
authors.initials: CM
authors.lastname: O'Connor
mesh_terms: D002316:Cardiotonic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004280:Dobutamine / Q000627:therapeutic use*; D004311:Double-Blind Method; D023381:Endpoint Determination; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D015337:Multicenter Studies as Topic / Q000379:methods*; D045283:Natriuretic Agents / Q000627:therapeutic use*; D020097:Natriuretic Peptide, Brain; D018579:Patient Selection; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
chemical_list: D002316:Cardiotonic Agents; D045283:Natriuretic Agents; D019210:Troponin I; D020107:Troponin T; D020097:Natriuretic Peptide, Brain; D004280:Dobutamine